Lead Product(s) : Undisclosed
Therapeutic Area : Genetic Disease
Study Phase : Discovery Platform
Sponsor : Casma Therapeutics
Deal Size : Undisclosed
Deal Type : Agreement
Casma Therapeutics and Vipergen Enter Into Drug Discovery Agreement
Details : Under the terms of the agreement, Vipergen will apply its proprietary high-fidelity DNA-encoded library (DEL) technology platform to discover novel small-molecule drug leads against a broad range of undisclosed Casma discovery targets.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
January 12, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Genetic Disease
Highest Development Status : Discovery Platform
Sponsor : Casma Therapeutics
Deal Size : Undisclosed
Deal Type : Agreement